UPDATE 1-Biogen delays Alzheimer's drug filing plans, shares fall
April 22, 2020 at 07:46 AM EDT
Biogen Inc said on Wednesday it would delay filing for marketing approval of its much-awaited experimental Alzheimer's disease drug to the third quarter, sending its shares down 7%.
